| Literature DB >> 35778402 |
W Éamon Callison1, Melisa Kiyamu2, Francisco C Villafuerte2, Tom D Brutsaert3, Daniel E Lieberman4.
Abstract
Despite aerobic activity requiring up to tenfold increases in air intake, human populations in high-altitude hypoxic environments can sustain high levels of endurance physical activity. While these populations generally have relatively larger chest and lung volumes, how thoracic motions actively increase ventilation is unknown. Here we show that rib movements, in conjunction with chest shape, contribute to ventilation by assessing how adulthood acclimatization, developmental adaptation, and population-level adaptation to high-altitude affect sustained aerobic activity. We measured tidal volume, heart rate, and rib-motion during walking and running in lowland individuals from Boston (~ 35 m) and in Quechua populations born and living at sea-level (~ 150 m) and at high altitude (> 4000 m) in Peru. We found that Quechua participants, regardless of birth or testing altitudes, increase thoracic volume 2.0-2.2 times more than lowland participants (p < 0.05). Further, Quechua individuals from hypoxic environments have deeper chests resulting in 1.3 times greater increases in thoracic ventilation compared to age-matched, sea-level Quechua (p < 0.05). Thus, increased thoracic ventilation derives from a combination of acclimatization, developmental adaptation, and population-level adaptation to aerobic demand in different oxygen environments, demonstrating that ventilatory demand due to environment and activity has helped shape the form and function of the human thorax.Entities:
Mesh:
Year: 2022 PMID: 35778402 PMCID: PMC9249887 DOI: 10.1038/s41598-022-13263-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1(A) The partial pressure of inspired oxygen decreases with elevation. Participant populations were from different oxygen environments and experiments took place at different altitudes. (B) A participant outfitted with our nanocomposite devices, mask, and spirometer. (C) Approximate device placement on human participants (ventral view) corresponding to thoracic circumference measurements.
Figure 2The thorax increases in volume during ventilation due to the action of the ribs through the pump-handle and bucket-handle motions. Changes in the maximum circumference of the thorax during ventilation result from the pump-handle (dorsoventral; red) and bucket-handle (mediolateral; blue) rib motions in humans.
Participant anthropometrics, with values given as mean ± SD. NS: not significant; *: p ≤ 0.05; **: p ≤ 0.01; ***: p ≤ 0.001.
| QLHA (n = 20) | QMSL (n = 17) | QBSL (n = 16) | LSL (n = 15) | |
|---|---|---|---|---|
| Age (years) | 23.15 (± 3.23)NS(QMSL),NS(QBSL),NS(LSL) | 24.29 (± 3.27)NS(QHLA),NS(QBSL),NS(LSL) | 24.06 (± 3.40)NS(QHLA),NS(QMSL),NS(LSL) | 22.73 (± 4.01)NS(QHLA), NS(QMSL),NS(QBSL) |
| Standing height (cm) | 164.78 (± 5.82)NS(QMSL),NS(QBSL),***(LSL) | 165.57 (± 5.01)NS(QLHA),NS(QBSL),***(LSL) | 166.09 (± 5.49)NS(QLHA),NS(QMSL),***(LSL) | 178.93 (± 5.65)***(QLHA),***(QMSL),***(QBSL) |
| Body mass (kg) | 64.94 (± 10.61)NS(QMSL),NS(QBSL),*(LSL) | 67.97 (± 8.10)NS(QLHA),NS(QBSL),NS(LSL) | 70.83 (± 9.98)NS(QLHA),NS(QMSL),NS(LSL) | 72.51 (± 8.51)*(QLHA),NS(QMSL),NS(QBSL) |
| Sitting height (cm) | 88.68 (± 2.82)NS(QMSL),NS(QBSL),***(LSL) | 88.41 (± 2.16)NS(QHLA),NS(QBSL),***(LSL) | 89.36 (± 3.55)NS(QHLA),NS(QMSL),**(LSL) | 94.12 (± 2.97)***(QLHA),***(QMSL),**(QBSL) |
| BMI | 23.89 (± 3.47)NS(QMSL),NS(QBSL),NS(LSL) | 24.79 (± 2.72)NS(QLHA),NS(QBSL),*(LSL) | 25.67 (± 3.22)NS(QLHA),NS(QMSL),*(LSL) | 22.70 (± 3.04)NS(QLHA),*(QMSL),*(QBSL) |
| Resting chest depth (cm) | 24.91 (± 4.10)NS(QMSL),NS(QBSL),NS(LSL) | 25.56 (± 1.64)NS(QLHA),*(QBSL),*(LSL) | 23.84 (± 2.83)NS(QLHA),*(QMSL), NS(LSL) | 23.89 (± 1.72)NS(QLHA),*(QMSL),NS(QBSL) |
| Resting middle chest width (cm) | 31.20 (± 1.55)NS(QMSL),NS(QBSL),NS(LSL) | 31.00 (± 3.18)NS(QLHA),NS(QBSL),NS(LSL) | 32.14 (± 2.79)NS(QLHA),NS(QMSL),NS(LSL) | 30.87 (± 2.04)NS(QLHA),NS(QMSL),NS(QBSL) |
| Resting chest volume (L) | 11.05 (± 2.71)NS(QMSL),NS(QBSL),***(LSL) | 11.17 (± 2.17)NS(QLHA),NS(QBSL),***(LSL) | 12.53 (± 2.90)NS(QLHA),NS(QMSL),***(LSL) | 17.44 (± 2.36)***(QLHA),***(QMSL),***(QBSL) |
Figure 3Absolute thoracic expansion and contraction (L) increased with absolute VT (L) significantly more in QLHA (slope ± S. 0.75 ± 0.03, R2 = 0.81; p = 0.002), QMSL (0.81 ± 0.04, R2 = 0.87; p < 0.001) and QBSL (0.83 ± 0.06, R2 = 0.82; p < 0.001) than in LSL (0.57 ± 0.05, R2 = 0.52) participants. Shading represents 95% CIs.
Figure 4(A) Thoracic expansion and contraction relative to chest volume increased with mass-specific VT (L/kg) in QLHA (slope ± S. 4.49 ± 0.23, R2 = 0.47), QMSL (4.84 ± 0.24, R2 = 0.66), QBSL (4.51 ± 0.24, R2 = 0.50), and LSL (2.27 ± 0.17, R2 = 0.36) participants. Shading represents 95% CIs. (B) Normalized thoracic ventilation, or the amount air inhaled per minute using the chest normalized to average chest volume, increases with fH,scope in all populations. (C) Normalized thoracic ventilation increases with mass-specific E (L/min/kg-BTPS) in QLHA (slope ± S. 4.74 ± 0.19, R2 = 0.80), QMSL (4.94 ± 0.23, R2 = 0.78), QBSL (4.18 ± 0.22, R2 = 0.78) and LSL (2.26 ± 0.15, R2 = 0.55) participants. Shading represents 95% CIs. Multiple measures from individual participants are presented together for graphical clarity. Repeated measures in participants are accounted for and fixed effects assessed via non-linear mixed effects models using generalized least squares (see “Statistical analysis”).
Figure 5Normalized thoracic ventilation (the amount air inhaled per minute using the chest normalized to average chest volume) increases with mass-specific O2 ventilation (moles/min/kg) in QLHA participants (slope ± S. 885.01 ± 34.82, R2 = 0.80), QMSL (527.98 ± 24.99, R2 = 0.78), QBSL (445.90 ± 22.99, R2 = 0.78) and LSL participants (241.23 ± 16.05, R2 = 0.55). Shading represents 95% CIs. Multiple measures from individual participants are presented together for graphical clarity. Repeated measures in participants are accounted for and fixed effects assessed via non-linear mixed effects models using generalized least squares (see “Statistical analysis”).
Figure 6(A) Dorsoventral expansion normalized to chest depth (PH) drives increases in thoracic volume. Mass-specific VT (L/kg-BTPS) increases with both dorsoventral and mediolateral thoracic expansion in all populations. Mass-specific VT (L/kg-BTPS) increased with maximum dorsoventral expansion relative to chest depth more in LSL participants (slope ± S. 0.37 ± 0.02, R2 = 0.70) than Quechua participants (p < 0.01). QLHA (0.35 ± 0.02, R2 = 0.72; p = 0.006) and QMSL (0.32 ± 0.02, R2 = 0.73; p = 0.091) increased more than QBSL (0.27 ± 0.02, R2 = 0.60). Mass-specific VT (L/kg-BTPS) also increased with maximum mediolateral expansion relative to chest width significantly more in LSL participants (0.51 ± 0.03, R2 = 0.71) than QLHA (p = 0.005), QMSL (p < 0.001) and QBSL (p < 0.001) participants. QLHA (0.42 ± 0.02, R2 = 0.73) exhibited greater amounts of mediolateral expansion normalized to chest width (BH) relative to QMSL (0.35 ± 0.02, R2 = 0.82; p = 0.020) and QBSL (0.36 ± 0.02, R2 = 0.73; p = 0.081). QMSL and QBSL did not differ significantly (p = 0.739). Shading represents 95% CLs. (B) Change in thoracic volume relative to chest volume increased with maximum dorsoventral expansion relative to chest depth (PH) more in QLHA (p < 0.001), QMSL (p < 0.001) and QBSL (p = 0.101) participants than in LSL participants (slope ± S. 1.03 ± 0.07, R2 = 0.47). QLHA (1.64 ± 0.12, R2 = 0.44) and QMSL (1.62 ± 0.12, R2 = 0.56) exhibited similar amounts of thoracic volume change relative to dorsoventral expansion (p = 0.927), while QBSL (1.27 ± 0.13, R2 = 0.37) had less thoracic volume change resulting from similar amounts of dorsoventral expansion than QLHA (p = 0.038) and QMSL (p = 0.042) participants. Change in thoracic volume relative to chest volume increased with maximum mediolateral expansion relative to chest width (BH) more in QLHA (p < 0.001), QMSL (p = 0.015) and QBSL (p = 0.187) participants than in LSL participants (1.35 ± 0.12, R2 = 0.34). QLHA (2.07 ± 0.13, R2 = 0.43), QMSL (1.76 ± 0.11, R2 = 0.68; p = 0.075) and QBSL (1.61 ± 0.15, R2 = 0.38; p = 0.024) exhibited similar amounts of thoracic volume change relative to dorsoventral expansion. QMSL and QBSL were not significantly different (p = 0.439). Shading represents 95% CIs. Multiple measures from individual participants are presented together for graphical clarity. Repeated measures in participants are accounted for and fixed effects assessed via non-linear mixed effects models using generalized least squares (see “Statistical analysis”).